Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | Ruxolitinib | 0.3 | uM | EGF | 100 | ng/mL | 3 | IL-2 | 52.0 | 79 | |
N2586 | Tofacitinib | 0.3 | uM | EGF | 100 | ng/mL | 3 | IL-2 | 41.5 | 66 | |
N2586 | IKK16 | 2.0 | uM | EGF | 100 | ng/mL | 3 | IL-2 | 34.5 | 86 | |
N2586 | JNK-IN-11 | 0.3 | uM | 3 | IL-2 | 46.0 | 61 | ||||
RA2159 | 3 | IL-2 | 50.0 | 95 | |||||||
RA2159 | PD184352 | 0.1 | uM | 3 | IL-2 | 48.0 | 53 | ||||
RA2159 | Lestaurtinib | 0.3 | uM | 3 | IL-2 | 45.0 | 57 | ||||
RA2159 | Ruxolitinib | 0.3 | uM | 3 | IL-2 | 51.0 | 72 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 3 | IL-2 | 55.0 | 67 | ||||
RA2159 | IKK16 | 2.0 | uM | 3 | IL-2 | 48.0 | 76 | ||||
RA2159 | JNK-IN-8 | 3.0 | uM | 3 | IL-2 | 45.0 | 79 | ||||
N2586 | 3 | IL-2 | 48.5 | 82 | |||||||
N2586 | PD184352 | 0.1 | uM | 3 | IL-2 | 44.5 | 90 | ||||
N2586 | Lestaurtinib | 0.3 | uM | 3 | IL-2 | 51.5 | 66 | ||||
N2586 | Ruxolitinib | 0.3 | uM | 3 | IL-2 | 49.0 | 74 | ||||
N2586 | Tofacitinib | 0.3 | uM | 3 | IL-2 | 45.0 | 75 | ||||
N2586 | IKK16 | 2.0 | uM | 3 | IL-2 | 48.0 | 51 | ||||
N2586 | JNK-IN-8 | 3.0 | uM | 3 | IL-2 | 45.0 | 67 | ||||
RA2159 | IL-17A | 100 | ng/mL | 3 | IL-2 | 53.0 | 89 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-17A | 100 | ng/mL | 3 | IL-2 | 58.5 | 78 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | IL-2 | 55.0 | 86 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | IL-2 | 51.0 | 87 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | IL-2 | 48.0 | 75 | |
RA2159 | IKK16 | 2.0 | uM | IL-17A | 100 | ng/mL | 3 | IL-2 | 47.0 | 69 | |
N2586 | IL-17A | 100 | ng/mL | 3 | IL-2 | 55.0 | 70 |